IXHL Earnings & Financial Statements
Incannex Healthcare Limited
$2.76
+$0.02(+0.62%)
41
Overall
60
Value
20
Tech
44
Quality
Market Cap
$34.44M
Volume
24.06K
52W Range
$2.49 - $14.91
Target Price
$18.00
IXHL earnings and financial statements: Incannex Healthcare Limited's income statement, balance sheet and cash flow statement, annual and quarterly.
IXHL Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $86.0K | $12.0K | - | - |
| Cost of revenue | - | - | - | $6.3K |
| Operating income | -$23.79M | -$30.04M | -$21.36M | -$15.56M |
| EBITDA | -$46.34M | -$18.33M | -$19.85M | -$14.90M |
| Net income | -$46.88M | -$18.46M | -$19.98M | -$14.90M |
| EPS (diluted) | $-1.35 | $-34.50 | $-0.01 | $-1.25 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total assets | $20.45M | $17.05M | $88.59M | $37.88M |
| Total liabilities | $7.06M | $5.83M | $4.46M | $2.01M |
| Shareholders’ equity | $13.39M | $11.22M | $84.13M | -$50.72M |
| Cash and equivalents | $15.00M | $5.90M | $33.36M | $37.50M |
| Long-term debt | $74.0K | $210.0K | $616.1K | - |
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating cash flow | -$12.50M | -$15.85M | -$15.94M | -$12.81M |
| Capital expenditure | -$8.0K | -$277.0K | - | - |
| Free cash flow | -$12.51M | -$16.12M | -$16.42M | -$12.81M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IXHL | $2.76 | +0.6% | 24.06K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Incannex Healthcare Limited Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW